Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Axelrod

Showing results (341-350 of 353) with videos related to

Pageof 36
Sort By:
Head & Neck|July 3, 2014
Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathwaysMark J Axelrod, Rolando E Mendez, Ashraf Khalil, et al.
Cell Death & Disease|October 31, 2014
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinomaK E McCabe, K Bacos, D Lu, et al.
Science (New York, N.Y.)|June 11, 2026
Laser phase plate improves structure determination of small proteins by cryo-EMPetar N Petrov, Jessie T Zhang, Jonathan Remis, et al.
FEBS Letters|September 16, 1996
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratC C Felder, A Nielsen, E M Briley, et al.
Journal of Children'S Orthopaedics|October 9, 2018
Olecranon fractures in children and adolescents: outcomes based on fracture fixationC A Perkins, M T Busch, M A Christino, et al.
The Journal of Animal Ecology|December 29, 2023
Evolutionary divergence of developmental plasticity and learning of mating tactics in Trinidadian guppiesYusan Yang, Caleb J Axelrod, Elly Grant, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseasesF Hirata, R del Carmine, C A Nelson, et al.
American Journal of Public Health|March 1, 1971
Report of the committee on professional education, 1970J D Porterfield, S J Axelrod, A G Bridge, et al.
Blood Advances|October 17, 2017
Microenvironmental agonists generate <i>de novo</i> phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCLKallesh D Jayappa, Craig A Portell, Vicki L Gordon, et al.
The Laryngoscope|August 22, 2019
Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinomaChristine E Lehman, Ashraf A Khalil, Mark J Axelrod, et al.
Pageof 36

Showing results (341-350 of 353) with videos related to

Sort By:
Pageof 36
Head & Neck|July 3, 2014
Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathwaysMark J Axelrod, Rolando E Mendez, Ashraf Khalil, et al.
Cell Death & Disease|October 31, 2014
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinomaK E McCabe, K Bacos, D Lu, et al.
Science (New York, N.Y.)|June 11, 2026
Laser phase plate improves structure determination of small proteins by cryo-EMPetar N Petrov, Jessie T Zhang, Jonathan Remis, et al.
FEBS Letters|September 16, 1996
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratC C Felder, A Nielsen, E M Briley, et al.
Journal of Children'S Orthopaedics|October 9, 2018
Olecranon fractures in children and adolescents: outcomes based on fracture fixationC A Perkins, M T Busch, M A Christino, et al.
The Journal of Animal Ecology|December 29, 2023
Evolutionary divergence of developmental plasticity and learning of mating tactics in Trinidadian guppiesYusan Yang, Caleb J Axelrod, Elly Grant, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseasesF Hirata, R del Carmine, C A Nelson, et al.
American Journal of Public Health|March 1, 1971
Report of the committee on professional education, 1970J D Porterfield, S J Axelrod, A G Bridge, et al.
Blood Advances|October 17, 2017
Microenvironmental agonists generate <i>de novo</i> phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCLKallesh D Jayappa, Craig A Portell, Vicki L Gordon, et al.
The Laryngoscope|August 22, 2019
Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinomaChristine E Lehman, Ashraf A Khalil, Mark J Axelrod, et al.
Pageof 36